MENU

Can Resolute Holdings Management (RHLD) Stock Reach $181?

A.I.Advisor
published price charts
A.I.Advisor
Nov 09, 2026

Can Resolute Holdings Management (RHLD) Stock Reach $181?

Key Takeaways

  • The central price objective used here is $181, roughly 10% above the latest verified price of about $164 (NYSE close on November 9, 2026).
  • This figure is not a consensus; it reflects the most recent single-analyst objective cited in public coverage (a Buy with a $181 target), because Resolute Holdings has too little active analyst coverage for a meaningful average.
  • Published analyst targets for Resolute Holdings Management, Inc. (RHLD) have ranged widely, from about $123 (Hold) to $229 (Buy), illustrating sharp disagreement as the stock has swung dramatically.
  • Supportive factors include a recurring management-fee business model, the company's close tie to CompoSecure, and strong recent momentum (a more than 40% one-month rally).
  • Principal risks include extreme volatility, a thin float, reported net losses, and heavy dependence on CompoSecure and a planned transaction with Husky.
  • For deeper context, explore RHLD's Major News, Today's Price Move, Forecast, and Earnings pages.
  • You can also explore Trending AI Robots to see how AI-driven trading tools are monitoring opportunities across the market.

Analyst Price Targets and Consensus View

Resolute Holdings Management, Inc. (RHLD) is a New York–based alternative asset management platform that provides operating-management services, including oversight of capital allocation and M&A execution, to businesses such as CompoSecure and GPGI. Because the company was only incorporated in 2024 and has a small float, sell-side coverage is unusually thin. MarketBeat shows a single active rating (a Sell) and no consensus price target, while TipRanks has cited a most recent single-analyst objective of a Buy at $181, with earlier cited targets ranging from roughly $123 (Hold) to $229 (Buy).

With no credible multi-analyst consensus available, the $181 figure is treated here as a public-discussion reference point rather than an average analyst price target. Investors should understand that the wide $123-to-$229 range reflects a rapidly changing narrative more than settled valuation: the stock has moved from below $100 to above $236 and back within its 52-week span.

Current Market Position and Path Toward the Target

The latest verified price is roughly $164, giving required upside of about 10% to reach $181 — a modest move by percentage terms, though the stock's history shows it can travel that distance quickly in either direction. Resolute Holdings has a 52-week range of approximately $96.79 to $236.19, and after a steep decline early in 2026 it has rallied more than 40% over the past month. Reaching $181 would represent a partial retracement toward the January 2026 high, not a new record.

What Could Support a Move Toward the Target

The most important supportive factor is the recurring management-fee model at the core of the platform. Management has highlighted fee-related earnings per share (EPS) — a non-GAAP measure that strips out non-controlling interests and one-time items — as a better gauge of the underlying business than reported net income, which has been pressured by the company's structure. A recently expanded $30 million revolving credit facility and a completed reincorporation from Delaware to Nevada were both framed as steps to improve financial flexibility and corporate structure. Continued momentum in the alternative-asset-management space and any positive developments around the CompoSecure and Husky relationship could also lift sentiment.

What Could Prevent the Target From Being Reached

The risks are substantial. The stock is a micro-cap with a thin float and exceptionally high historical volatility, making it vulnerable to sharp drawdowns. Reported earnings attributable to common stockholders have been negative, and the company remains heavily dependent on CompoSecure and the outcome of its planned transaction with Husky — a source of both opportunity and complexity. A single analyst has carried a Sell rating, and institutional ownership is limited, meaning sentiment can shift quickly. Any deterioration in the CompoSecure relationship, weaker fee-related earnings, or a broader risk-off rotation in small-cap financials could stall a move toward $181.

Technical Levels and Market Structure

Durable levels matter more than short-term indicator readings for this name. The January 2026 peak near $236 stands as the major long-term resistance, while the March 2026 low near $97 is the key support floor. In the nearer term, the recent trading band between roughly $147 and $165 is worth watching; a decisive move above the upper end of that zone would put $181 within reach, whereas a break below the prior close near $153 could signal fading momentum.

Time Horizon and What Investors Should Monitor

Single-analyst price targets generally reflect a research horizon of roughly 12 months, but with such thin coverage there is no firm consensus to anchor a timeline. Investors should monitor quarterly earnings and fee-related earnings disclosures, any updates to the CompoSecure and Husky transaction, further credit-facility or balance-sheet announcements, and any new analyst initiations or rating changes. Small-cap sentiment and broader interest-rate expectations can also drive this high-beta name.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a highly volatile, thinly covered name like RHLD, such tools can help traders discover opportunities, monitor positions, and spot shifting trends more efficiently than manual screening alone. Explore the signals to see how AI is interpreting the current setup.

Final Assessment

Can RHLD reach $181? The level represents only about a 10% move from the latest price, so it is far from out of reach — but the path is not assured. The stock benefits from a recurring-fee business model and strong recent momentum, yet it also carries exceptional volatility, reported net losses, and concentrated exposure to CompoSecure and the Husky transaction. With analyst coverage effectively limited to a single active voice and targets spanning $123 to $229, there is no reliable consensus to lean on. The $181 objective should be read as one publicly discussed reference point, not a forecast, and investors should watch earnings, deal developments, and the technical zone near $165 for the next clues.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
Interact to see
Advertisement

RHLD and Stocks

Correlation & Price change

A.I.dvisor tells us that RHLD and TIC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RHLD and TIC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHLD
1D Price
Change %
RHLD100%
-5.85%
TIC - RHLD
32%
Poorly correlated
-5.78%
BKSY - RHLD
26%
Poorly correlated
-12.88%
SPIR - RHLD
24%
Poorly correlated
-7.30%
AZZ - RHLD
22%
Poorly correlated
-4.58%
QUAD - RHLD
21%
Poorly correlated
-2.17%
More

Groups containing RHLD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHLD
1D Price
Change %
RHLD100%
-5.85%
Producer Manufacturing
category (346 stocks)
7%
Poorly correlated
-4.26%
Office Equipment/Supplies
category (45 stocks)
-5%
Poorly correlated
-2.33%